AU3548895A - Phosphorus-32 labeling of antibodies for cancer therapy - Google Patents

Phosphorus-32 labeling of antibodies for cancer therapy

Info

Publication number
AU3548895A
AU3548895A AU35488/95A AU3548895A AU3548895A AU 3548895 A AU3548895 A AU 3548895A AU 35488/95 A AU35488/95 A AU 35488/95A AU 3548895 A AU3548895 A AU 3548895A AU 3548895 A AU3548895 A AU 3548895A
Authority
AU
Australia
Prior art keywords
labeling
antibodies
phosphorus
cancer therapy
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35488/95A
Inventor
Gary L. Griffiths
Hans J. Hansen
Shui-On Leung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of AU3548895A publication Critical patent/AU3548895A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU35488/95A 1994-09-16 1995-09-18 Phosphorus-32 labeling of antibodies for cancer therapy Abandoned AU3548895A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30810394A 1994-09-16 1994-09-16
US308103 1994-09-16
PCT/US1995/011405 WO1996008506A1 (en) 1994-09-16 1995-09-18 Phosphorus-32 labeling of antibodies for cancer therapy

Publications (1)

Publication Number Publication Date
AU3548895A true AU3548895A (en) 1996-03-29

Family

ID=23192557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35488/95A Abandoned AU3548895A (en) 1994-09-16 1995-09-18 Phosphorus-32 labeling of antibodies for cancer therapy

Country Status (6)

Country Link
EP (1) EP0783516A4 (en)
JP (1) JPH10511263A (en)
AU (1) AU3548895A (en)
CA (1) CA2200088A1 (en)
IL (1) IL115177A0 (en)
WO (1) WO1996008506A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874540A (en) * 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
ES2400181T3 (en) * 2002-08-19 2013-04-08 Merck Patent Gmbh Variants of the major allergen PHI P 1 of herb timotea
JP4790413B2 (en) 2002-10-08 2011-10-12 イミューノメディクス、インコーポレイテッド Antibody therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077195A (en) * 1985-03-01 1991-12-31 Board Of Reagents, The University Of Texas System Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
US4923802A (en) * 1985-06-13 1990-05-08 Immunex Corporation Peptide substrates for the detection, characterization and purification of protein kinase C
GB2186579B (en) * 1986-01-21 1990-07-25 Brian Maurice John Foxwell Improvements relating to the radio-labelling of proteins
GB8906708D0 (en) * 1989-03-23 1989-05-10 Foxwell Brian M J Improvements relating to the radiolabelling of proteins
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
ES2348458T3 (en) * 1991-04-19 2010-12-07 The Board Of Regents Of The University Of Washington DNA CODIFYING PHOSPHODESTERASES OF MAMMALS.
GB9126650D0 (en) * 1991-12-16 1992-02-12 Creighton Andrew M Further improvements relating to the radiolabelling of proteins
US5366889A (en) * 1992-11-30 1994-11-22 The General Hospital Corporation DNA encoding a protein-coupled receptor kinase

Also Published As

Publication number Publication date
WO1996008506A1 (en) 1996-03-21
JPH10511263A (en) 1998-11-04
CA2200088A1 (en) 1996-03-21
EP0783516A1 (en) 1997-07-16
IL115177A0 (en) 1995-12-31
EP0783516A4 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
AU5268696A (en) Novel compounds and methods for therapy
ZA9811314B (en) Novel compounds and methods for synthesis and therapy
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU2805195A (en) Therapeutic compounds
AUPO665397A0 (en) Novel therapy for constipation
AU4473596A (en) Methods of human prostate cancer diagnosis
AU5246398A (en) Magnetic therapy
AU5005697A (en) Methods of preventing breast cancer
HK1120494A1 (en) Novel compounds and methods for synthesis and therapy
AU8259798A (en) Method for detection of breast cancer
AU5300396A (en) Radiation enhanced gene therapy for treatment of tumors
GB9509572D0 (en) Cancer therapy
AU7166896A (en) Cancer treatment
AU7498296A (en) Use of protein gax for treating cancer
AU6012696A (en) Prognostic and therapeutic system for cancer
AU5298696A (en) Tumor marker protein for cancer risk assessment
AU3548895A (en) Phosphorus-32 labeling of antibodies for cancer therapy
AU4313396A (en) Antiperspirant pads
GB9703633D0 (en) Cancer therapy
AU3370095A (en) Methods of inhibiting endometrial cancer
AU4417996A (en) Treatment of prostate cancer
AU7130696A (en) Combination of beta-interferon for the treatment of prostate cancer
AU4502797A (en) Immunological therapy for cancer
AU2002227270A1 (en) Afterloader apparatus